Sunday, September 29, 2024
HomeIndustries

Industries

Vanda Pharmaceuticals Settles HETLIOZ® Patent Litigation with MSN

Vanda Pharmaceuticals Inc. (Vanda)  announced it has entered into a License Agreement (the License Agreement) with MSN Pharmaceuticals Inc., MSN Laboratories Private Limited (together...

Revelian Enters 2022 with New Brand Identity as Criteria – Further Positioning the Organization as a Multi-faceted Global Leader in the Talent Space

Revelian, a leader in the field of emotional intelligence and game-based assessments, announced that it has rebranded as Criteria. Criteria, a market-leading SaaS talent...

U.S. FDA Approves RINVOQ® (upadacitinib) to Treat Adults and Children 12 Years and Older with Refractory, Moderate to Severe Atopic Dermatitis

AbbVie announced the U.S. Food and Drug Administration (FDA) has approved RINVOQ® (upadacitinib) for the treatment of moderate to severe atopic dermatitis in adults...

Jacobio Receives IND Approval for Aurora A Inhibitor JAB-2485 from FDA

Jacobio's self-developed global first-in-class drug Aurora A inhibitor JAB-2485 received IND (Investigational New Drug) from the FDA (Food and Drug Administration) in US. Jacobio...

Xoran to Showcase vTRON™ at VMX 2022 Veterinary Meeting & Expo

Xoran Technologies' revolutionary, truly mobile 3D computed tomography (CT) imaging solution, vTRON™ has been selected by the North American Veterinary Community (NAVC) of industry...
0FansLike
0FollowersFollow
spot_img

Hot Topics